News

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...
Researchers at Radboud University and the Radboudumc found that mothers with postpartum depression benefit from oxytocin nasal spray. The oxytocin causes mothers to respond more positively to their ...
A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.
Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable depression. The HHS and FDA voice support for psychedelics.
Credence Behavioral Health opened its doors in Lynchburg. Now, the outpatient clinic is serving over 1,700 patients, and ...
AbbVie ABBV holds a leadership position in the neuroscience space, which encompasses blockbuster medications such as Botox ...
Dividend stocks are one of the most powerful investing tools to build wealth. The S&P 500 has plenty of magnificent dividend ...
After drowning in his hot tub at 54, Matthew Perry's doctor pleaded guilty to distributing the drug that helped kill him.
Fragrance has entered the wellness and aromatherapy space. Discover the new scents designed to lower stress levels and ...
Historically, Johnson & Johnson has been a fairly stable stock to own. Johnson & Johnson (NYSE: JNJ) has been a leading ...
“The opioids, Carfentanil and fentanyl, they actually cause what’s called respiratory depression,” Bagdasarian said. “They ...
About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets ...